SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Torben Noerup Nielsen who wrote (29493)11/27/1999 5:04:00 PM
From: Arthur Radley  Respond to of 32384
 
Torben,
A good example of shorting the stock prior to conversion of warrants can be seen with TTP(another biotech). Go back and look at the trading pattern after they announced the warrant conversion(dropped like a rock)...and now since the conversion is over, look at the trading pattern in the common(hit a new high yesterday). By shorting the stock, they "shake the tree" and get unsuspecting investors to turn loose their warrants, knowing full well that they will get the common shares on the cheap with the discounted warrants.



To: Torben Noerup Nielsen who wrote (29493)11/27/1999 6:37:00 PM
From: celeryroot.com  Respond to of 32384
 
if short at 10 1/8 buy warrants at 3.5 exercise nice deal



To: Torben Noerup Nielsen who wrote (29493)11/27/1999 8:27:00 PM
From: D.Lu  Read Replies (2) | Respond to of 32384
 
Came to the same conclusion. The warrents sat still while the common climbed and then played catch up later on. The volume on both leads me to believe that there is a buyer in a hurry to accumulate, perhaps ahead of news soon to come. From another perspective, LGND's price is embarassingly low compared to some other biotechs that formerly tended to track together- ie ISIP VCAL.

Yes Texas, an orchestrated shakeout of the warrent holders may contribute as well. I'm ready to believe most anything. May the best come to be. This stock is long overdue for a runup IMO.